Anzeige
❌
Mehr »
Donnerstag, 05.11.2026 - Börsentäglich über 12.000 News
Umsatz +31 %, Analysten mit Rating: KAUFEN - Aktie mit 200 % Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von MassDevice

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
15:58Smith+Nephew CEO confirms that ortho megamerger talks fell apart
15:58Smith+Nephew CEO confirms ortho megamerger talks fell apart
14:58Siemens Healthineers to drop 'Siemens' from name, spin off Diagnostics
00:58Edwards Lifesciences CEO says 'more competition is coming' in TAVR
MiThe top cardiovascular tech stories from TCT 2026
MiLivaNova shares explode as it eyes OSA neuromod entry
MiMiniMed names new CMO ahead of planned retirement
MiInsulet earnings trounce Q3 estimates as it narrows guidance
MiMedline plans to increase prices in 2027 to offset inflation pressures, reports strong Q3 results
MiZimmer Biomet CEO doesn't see slowdown in ortho procedures
DiBoston Scientific Watchman study pitches simpler drug regimens after LAAO procedures
DiBoston Scientific, Blackstone sign $455M deal for heart pump co-development
DiInspire Medical stock drops despite beating Q3 expectations
DiPhilips sets aside €288M for DOJ settlement over CPAP recall
MoEdwards trial illustrates impact of moving TAVR into moderate aortic stenosis
MoGE HealthCare unveils ceiling-mounted Allia Celeo image-guided system
MoPhilips launches HyperVue Integrated in the United States
MoAbbott's next-gen Amulet 360 LAA occluder delivers one-year data
MoAbbott, J&J spotlight clinical successes in coronary intravascular lithotripsy
MoFlow Medical raises $6M in round with strategic investors
FrDexcom Q3 earnings top forecasts, as it looks ahead to type 2 coverage
FrStryker stock down on Q3 misses amid health insurance headwinds
FrResmed beats earnings expectations but sticks with prior guidance
29.10.BD begins US rollout of next-gen liver stent graft
29.10.Lambda Surgical guidance platform gets approval for first-in-human